Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms: HELP
Articles by Emrah Alper
Based on 3 articles published since 2009
(Why 3 articles?)

Between 2009 and 2019, Emrah Alper wrote the following 3 articles about Pancreatic Neoplasms.
+ Citations + Abstracts
1 Review Endoscopic ultrasound-guided tissue sampling: How can we improve the results? 2016

Alper, Emrah / Onur, İrem / Arabul, Mahmut / Ünsal, Belkıs. ·Department of Gastroenterology, Katip Çelebi University, İzmir Atatürk Training and Research Hospital, İzmir, Turkey. mahmutarabul@gmail.com. ·Turk J Gastroenterol · Pubmed #26728860.

ABSTRACT: Endoscopic ultrasound (EUS) enables a gastroenterologist to sample the masses of the middle and inferior mediastinum, which are adjacent to the esophagus; cystic or solid lesions of the pancreas, which are adjacent to the stomach and duodenum; and perirectal lesions. Needles used for EUS sampling include aspiration (19, 20, and 22 Gauge) or core biopsy needles (ProCore and Trucut) (19, 20, and 22 Gauge). The type and size of EUS needles do not alter the diagnostic results. Rapid on-site cytopathological evaluation will increase the diagnostic efficacy to 100% without prolonging the procedure time. Diagnostic efficacy of EUS-guided fine-needle aspiration or core biopsy depends on the experience of an endoscopist and a cytopathologist. In the presence of an experienced endoscopist and cytopathologist, the size of the needle does not have any significant impact on the diagnostic success.

2 Clinical Trial Comparison of multidetector CT and endoscopic ultrasonography in malignant pancreatic mass lesions. 2012

Arabul, Mahmut / Karakus, Funda / Alper, Emrah / Kandemir, Altay / Celik, Mustafa / Karakus, Volkan / Yucel, Kamil / Unsal, Belkis. ·Department of Gastroenterology, Izmir Ataturk Training and Research Hospital, Izmir, Turkey. mahmutarabuk@gmail.com ·Hepatogastroenterology · Pubmed #22155849.

ABSTRACT: BACKGROUND/AIMS: Endoscopic ultrasonography (EUS) has been shown to be superior to conventional CT in detecting and staging pancreatic cancer. We conducted a prospective trial to compare EUS and MDCT, in discriminating benign/malignant, in determining local and vascular invasion of a suspected pancreatic cancer and deciding its resectability. METHODOLOGY: The study was performed at the Gastroenterology Department of Izmir Ataturk Training and Research Hospital, from June 2009 to June 2010, all patients with suspected pancreatic and periampullary tumors referred to our department were enrolled. A total of 56 patients were evaluated at the beginning. Five patients having distal CBD tumor (n=2), gallbladder tumor (n=1) and papillary tumor (n=2) were excluded from the study. Analysis was done for the remaining 51 patients. RESULTS: For the diagnosis of resectability/unresectability, EUS alone demonstrated a definite role in 4 (9%) of the 43 patients in confirming surgical and pathologic results and MDCT alone demonstrated a definite role in 6 (14%) of the 43 patients in confirming their results. An accurate diagnostic decision regarding resectability/unresectability was accomplished in 27 (63%) patients with EUS and MDCT. CONCLUSIONS: While MDCT is clinically quite effective, in terms of a correct resectability/unresectability decision, EUS should also be used.

3 Minor EUS-FNA versus ERCP-guided sampling for suspected malignant biliary obstruction: which to choose? 2015

Ustundag, Yucel / Alper, Emrah / Fusaroli, Pietro. ·Department of Internal Medicine, Gastroenterology Clinics, Bulent Ecevit University, Zonguldak, Turkey. · Katip Celebi University Hospital, Izmir, Turkey. · Gastroenterology Unit, Imola Hospital, Bologna University, Bologna, Italy. ·Gastrointest Endosc · Pubmed #25527061.

ABSTRACT: -- No abstract --